Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 41: 147-152, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roheim, P. S.
Right arrow Articles by Asztalos, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roheim, P. S.
Right arrow Articles by Asztalos, B. F.

Clinical Chemistry, Vol 41, 147-152, Copyright © 1995 by American Association for Clinical Chemistry

Clinical significance of lipoprotein size and risk for coronary atherosclerosis

PS Roheim and BF Asztalos
Louisiana State University Medical Center, Department of Physiology, New Orleans 70112-2822.

Correlation between coronary heart disease and lipoprotein size and composition is well documented. Within the low-density lipoprotein (LDL) family the small LDL particles are associated with increased risk of coronary heart disease. These particles also have increased apolipoprotein (apo) B content. The appearance of these small LDL particles is the manifestation of complex alteration of plasma lipoprotein metabolism. The LDL size is influenced by genetic, endocrine, and environmental factors. Within the high-density lipoprotein (HDL) family the decrease of larger HDL2 particles is associated with coronary heart disease. HDLs can also be separated according to their apoprotein composition into particles containing lipoprotein (Lp)A-I only and particles containing LpA-I and LpA-II. Most studies have shown that the concentration of LpA-I-only particles decreases in coronary heart disease. HDLs are remodeled in the circulation and this remodeling continues in vitro after the blood is taken. Therefore adequate preservation of blood samples is necessary.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Lipid Res.Home page
G. L. Vega and G. Schonfeld
In Memoriam: Paul S. Roheim (1925-2008)
J. Lipid Res., March 1, 2009; 50(3): 361 - 363.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
I. J. Kullo and C. M. Ballantyne
Conditional Risk Factors for Atherosclerosis
Mayo Clin. Proc., February 1, 2005; 80(2): 219 - 230.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
D. L. Rainwater, P. H. Moore Jr., and I. O. Gamboa
Improved method for making nondenaturing composite gradient gels for the electrophoretic separation of lipoproteins
J. Lipid Res., April 1, 2004; 45(4): 773 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
I. Bureau, F. Laporte, M. Favier, H. Faure, M. Fields, A. E. Favier, and A.-M. Roussel
No Antioxidant Effect of Combined HRT on LDL Oxidizability and Oxidative Stress Biomarkers in Treated Post-Menopausal Women
J. Am. Coll. Nutr., August 1, 2002; 21(4): 333 - 338.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. E. Brousseau, J. J. O'Connor Jr, J. M. Ordovas, D. Collins, J. D. Otvos, T. Massov, J. R. McNamara, H. B. Rubins, S. J. Robins, and E. J. Schaefer
Cholesteryl Ester Transfer Protein TaqI B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency: Veterans Affairs HDL Cholesterol Intervention Trial
Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1148 - 1154.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Ordovas, L. A. Cupples, D. Corella, J. D. Otvos, D. Osgood, A. Martinez, C. Lahoz, O. Coltell, P. W. F. Wilson, and E. J. Schaefer
Association of Cholesteryl Ester Transfer Protein-TaqIB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk : The Framingham Study
Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1323 - 1329.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Coresh and P. O. Kwiterovich Jr
Small, Dense Low-Density Lipoprotein Particles and Coronary Heart Disease Risk: A Clear Association With Uncertain Implications
JAMA, September 18, 1996; 276(11): 914 - 915.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. F. Asztalos and P. S. Roheim
Presence and Formation of `Free Apolipoprotein A-I–Like' Particles in Human Plasma
Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1419 - 1423.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.